Voyager Therapeutics, Inc. (VYGR) revenue

Revenue · fiscal 2025
$40.37M

Voyager Therapeutics, Inc. (VYGR) reported revenue of $40.37M in fiscal 2025 (the year ended December 31, 2025). That is 49.5% lower than the $80.00M of fiscal 2024. Figures as of 18 Nov 2026, 12:14 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$40.37M
Change on fiscal 2024
−49.5%
Growth, 5 years
−25.1% a year
Growth, 10 years
+8.8% a year
Highest on record
$250.01Mfiscal 2023
Lowest on record
$7.62Mfiscal 2018
Fiscal years on record
112015–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Voyager Therapeutics, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue shrank at a compound 25.1% a year; over ten years the rate was 8.8% a year. Across the 11 fiscal years on record (2015–2025), the highest was $250.01M in fiscal 2023 and the lowest $7.62M in fiscal 2018.

History · 11 fiscal years

Revenue by fiscal year

Voyager Therapeutics, Inc. revenue, year by year

Voyager Therapeutics, Inc. (VYGR) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$40.37M 49.5% down
2024$80.00M 68.0% down
2023$250.01M 511.2% up
2022$40.91M 9.3% up
2021$37.42M 78.1% down
2020$171.13M 63.9% up
2019$104.39M 1,270.1% up
2018$7.62M 24.8% down
2017$10.14M 28.7% down
2016$14.22M 18.0% down
2015$17.33M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on VYGR

Voyager Therapeutics, Inc., figure by figure

Voyager Therapeutics, Inc. (VYGR) overview: price, valuation and scorecard

Voyager Therapeutics, Inc. revenue: questions and answers

What is Voyager Therapeutics, Inc.'s revenue?

Voyager Therapeutics, Inc. (VYGR) reported revenue of $40.37M in fiscal 2025 (the year ended December 31, 2025). That is 49.5% lower than the $80.00M of fiscal 2024.

What is the growth rate of Voyager Therapeutics, Inc.'s revenue?

Over the five fiscal years to 2025 revenue shrank at a compound 25.1% a year; over ten years the rate was 8.8% a year.

What are the highest and lowest revenue figures on record for Voyager Therapeutics, Inc.?

Across the 11 fiscal years on record (2015–2025), the highest was $250.01M in fiscal 2023 and the lowest $7.62M in fiscal 2018.

How is Voyager Therapeutics, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Voyager Therapeutics, Inc. it is on record here for 11 fiscal years, 2015 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Voyager Therapeutics, Inc. (VYGR) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/VYGR/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.